Your browser doesn't support javascript.
loading
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trial.
Zhou, Tie; Qin, Shengfei; Xu, Weidong; Tang, Shouyan; Chen, Guanghua; Li, Song; Hou, Jianguo; Gao, Xu; Shi, Guowei; Sun, Zhongquan; Jin, Jie; Chen, Lijun; Sun, Weibing; Liu, Ben; Wang, Jingen; Meng, Qinggui; Wang, Dongwen; Hu, Zhiquan; He, Dalin; Yang, Yong; Song, Xishuang; Fu, Cheng; Wang, Yinhuai; Ye, Dingwei; Zhang, Wei.
  • Zhou T; Department of Urology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Qin S; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Xu W; Department of Urology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Tang S; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Chen G; Department of Urology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Li S; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Hou J; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Gao X; Department of Urology, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Shi G; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Sun Z; Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
  • Jin J; Department of Urology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
  • Chen L; Department of Urology, Huadong Hospital, Fudan University, Shanghai, China.
  • Sun W; Department of Urology, Peking University First Hospital, Beijing, China.
  • Liu B; Department of Urology, 307 Hospital of People's Liberation Army, Beijing, China.
  • Wang J; Department of Urology, The Second Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Meng Q; Department of Urology, The First Affiliated Hospital of the Medical School of Zhejiang University, Hangzhou, China.
  • Wang D; Department of Urology, Jiangxi Province People's Hospital, Nanchang, China.
  • Hu Z; Department of Urology, Guangxi Tumor Hospital, Nanning, China.
  • He D; Department of Urology, The First Hospital of Shanxi Medical University, Taiyuan, China.
  • Yang Y; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Song X; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Fu C; Department of Urology, Peking University Cancer Hospital and Institute, Beijing, China.
  • Wang Y; Department of Urology, The First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Ye D; Department of Urology, Liaoning Cancer Hospital & Institute, Shenyang, China.
  • Zhang W; Department of Urology, Second Xiangya Hospital, Central South University, Changsha, China.
Int J Cancer ; 153(4): 792-802, 2023 08 15.
Article en En | MEDLINE | ID: mdl-36919366
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article